“…Much energy has been put into gene panels that would yield better prognostic and predictive tools for risk assessment (21)(22)(23), but the results are thus far disappointing, with no panels having reached widespread incorporation in clinical practice. The same goes for most other proposed prognostic systems (9,19,(24)(25)(26).…”